This Teen Is Almost 8 Feet Tall -- And Still Growing
At 7 feet 8 inches, Broc Brown definitely sticks out in a crowd, and he’s only going to get bigger. Brown’s family knew something was up at a young age: He was 5-foot-2 in kindergarten, according to his mother, Darci Elliot. “When he got into middle school he was around 6 feet tall, and by high school he was 7 feet tall,” Elliot told Barcroft TV. “It’s a genetic disorder and there’s nothing that can stop him from growing – I don’t know if he will ever stop.” Brown, 19, grows an astounding six inches a year because of a rare genetic disorder called Sotos syndrome, or cerebral gigantism. The condition reportedly affects 1 in 14,000 newborns, but the National Institutes of Health says the number may be closer to 1 in 5,000, since not everyone who has it is properly diagnosed. Kids with the syndrome tend to grow quickly in younger years and have unusually large heads, but their adult height is often in the normal range. That makes Brown a rarity among rarities. Other symptoms include attention deficit hyperactivity disorder and an explosive temper. Brown has both, his mother said. “When he gets mad, he’s mad. It wouldn’t take him two seconds to pop a hole in the wall ― it could be very dangerous if he wasn’t on medication and able to be calmed,” Elliot told Barcroft TV. “But overall, he is a big softie, his heart is as big as his body.” Brown is in cons...
29 September 2017, London, United Kingdom
29 September 2017, London, United Kingdom
Idiopathic condylar resorption is a rare and progressive entity that can result in an acquired dentofacial deformity to include retrogenia, apertognathia, and loss of posterior facial height secondary to condylar resorption and loss of ramus height. Additionally, patients may experience TMJ pain and dysfunction, myofascial pain, and headaches. Management strategies for ICR include both surgical and non-surgical treatment modalities.1,2
We report a rare case of lingual abscess caused by the tongue cancer in an elderly person. The patient was a 72-year-old man, who was seen in the dental clinic complaining that he had found it hard to eat due to pain and that his tongue had been swollen for the previous 3 days. He was referred to our hospital because of suspicion of the tongue tumor and hospitalized with dysphagia on November 21th, 2016.
Our genetic makeup can influence how we respond to medication, yet clinically we tend to prescribe medications in standard doses. Pharmacogenetic Testing gives insight into an individual ’s gene profile and can help predict optimal treatment. 14 colleagues were invited to participate in this study: 5 men and 9 women ages from 30 to 68 years. DNA samples were obtained from buccal mucosa swabs and underwent complete analysis for 19 genes and 180 commonly prescribed medications using GeneAlign PGx Genetic Testing (Chandler, AZ).
Oral surgery is a common source of opioid prescriptions, which have potential for misuse and abuse, with up to an estimated 23% of prescribed doses being used nonmedically.1,2 In most cases, such medication is obtained from friends or family members originally prescribed the medication; adolescents are at particular risk for resulting initial opioid exposure.1,2 We conducted a survey to examine opioid use for pain management after third molar extraction, focusing on prescribing practices and unused medication.
Dental pain and fear of oral surgery can affect patients ’ perceptions of their providers.1 Offering patients or parents of patients requiring surgery more information about a presenting dental problem, and treatment options, may alleviate anxiety and improve overall satisfaction.2 This survey was conducted to better understand patient preferences and a ttitudes about how their oral surgeon manages their pain.
Pain and swelling originating from a necrotic tooth is a common complaint in emergency departments, accounting for over 400,000 visits to emergency departments in the United States in the year 2006 alone. These patients present significant burdens on hospital budgets and provider time as both hospitals and clinicians are pressured to provide more cost-efficient care. One source of frustration and confusion that leads to inefficient treatment is the ambiguity of managing these infections by emergency medicine teams who triage these patients.
This study assessed outcomes for pulpal anesthesia, pain on injection, and time to sensation for Buffered 1% lidocaine with 1/100k epinephrine (Epi) vs. Non-buffered 2% lidocaine with 1/100k Epi.
The objective of this study was to determine the incidence of central sensitization and neuropathic pain conditions in patients with TMD and determine how these findings correlate with signs and symptoms based on JFLS scores and RDC/TMD criteria.